ReP USP - Resultado da busca

Artigo de periodico
Changes in contraceptive use during the second COVID-19 lockdown in Brazil: a web-based survey (2024)
Borges, Ana Luiza Vilela ; Lay, Alejandra Andrea Roman ; Duarte, Luciane Simões ; Chofakian, Christiane Borges do Nascimento ; Hall, Jennifer Anne; Barrett, Geraldine
Source: Contraception. Unidades: EE, EACH
Assunto: COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Ana Luiza Vilela et al. Changes in contraceptive use during the second COVID-19 lockdown in Brazil: a web-based survey. Contraception, v. 131, p. 01-06, 2024Tradução . . Disponível em: http://dx.doi.org/10.1016/j.contraception.2023.110359. Acesso em: 12 maio 2024.
APA
Borges, A. L. V., Lay, A. A. R., Duarte, L. S., Chofakian, C. B. do N., Hall, J. A., & Barrett, G. (2024). Changes in contraceptive use during the second COVID-19 lockdown in Brazil: a web-based survey. Contraception, 131, 01-06. doi:10.1016/j.contraception.2023.110359
NLM
Borges ALV, Lay AAR, Duarte LS, Chofakian CB do N, Hall JA, Barrett G. Changes in contraceptive use during the second COVID-19 lockdown in Brazil: a web-based survey [Internet]. Contraception. 2024 ; 131 01-06.[citado 2024 maio 12 ] Available from: http://dx.doi.org/10.1016/j.contraception.2023.110359
Vancouver
Borges ALV, Lay AAR, Duarte LS, Chofakian CB do N, Hall JA, Barrett G. Changes in contraceptive use during the second COVID-19 lockdown in Brazil: a web-based survey [Internet]. Contraception. 2024 ; 131 01-06.[citado 2024 maio 12 ] Available from: http://dx.doi.org/10.1016/j.contraception.2023.110359
Artigo de periodico
Recommendations for standardization of bleeding data analyses in contraceptive studies (2022)
Creinin, Mitchell D; Vieira, Carolina sales ; Westhoff, Carolyn L.; Mansour, Diana J. A.
Source: Contraception. Unidade: FMRP
Subjects: CONTROLE DE NATALIDADE, DISPOSITIVOS ANTICONCEPCIONAIS, MENSTRUAÇÃO, HEMORRAGIA, ANÁLISE DE DADOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CREININ, Mitchell D et al. Recommendations for standardization of bleeding data analyses in contraceptive studies. Contraception, v. 112, p. 14-22, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.contraception.2022.05.011. Acesso em: 12 maio 2024.
APA
Creinin, M. D., Vieira, C. sales, Westhoff, C. L., & Mansour, D. J. A. (2022). Recommendations for standardization of bleeding data analyses in contraceptive studies. Contraception, 112, 14-22. doi:10.1016/j.contraception.2022.05.011
NLM
Creinin MD, Vieira C sales, Westhoff CL, Mansour DJA. Recommendations for standardization of bleeding data analyses in contraceptive studies [Internet]. Contraception. 2022 ; 112 14-22.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2022.05.011
Vancouver
Creinin MD, Vieira C sales, Westhoff CL, Mansour DJA. Recommendations for standardization of bleeding data analyses in contraceptive studies [Internet]. Contraception. 2022 ; 112 14-22.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2022.05.011
Artigo de periodico
Predictors of severe pain during insertion of the levonorgestrel 52 mg intrauterine system among nulligravid women (2020)
Ferreira, Letícia Sanchez; Nadai, Mariane Nunes de ; Poli Netto, Omero Benedicto ; Franceschini, Silvio Antonio; Juliato, Cássia R.T.; Monteiro, Ilza Maria U.; Bahamondes, Luis; Vieira, Carolina Sales
Source: Contraception. Unidade: FMRP
Subjects: DISPOSITIVOS INTRAUTERINOS, MEDICAMENTO, GRAVIDEZ, DOR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Letícia Sanchez et al. Predictors of severe pain during insertion of the levonorgestrel 52 mg intrauterine system among nulligravid women. Contraception, v. 102, n. 4, p. 267-269, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.contraception.2020.07.004. Acesso em: 12 maio 2024.
APA
Ferreira, L. S., Nadai, M. N. de, Poli Netto, O. B., Franceschini, S. A., Juliato, C. R. T., Monteiro, I. M. U., et al. (2020). Predictors of severe pain during insertion of the levonorgestrel 52 mg intrauterine system among nulligravid women. Contraception, 102( 4), 267-269. doi:10.1016/j.contraception.2020.07.004
NLM
Ferreira LS, Nadai MN de, Poli Netto OB, Franceschini SA, Juliato CRT, Monteiro IMU, Bahamondes L, Vieira CS. Predictors of severe pain during insertion of the levonorgestrel 52 mg intrauterine system among nulligravid women [Internet]. Contraception. 2020 ; 102( 4): 267-269.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2020.07.004
Vancouver
Ferreira LS, Nadai MN de, Poli Netto OB, Franceschini SA, Juliato CRT, Monteiro IMU, Bahamondes L, Vieira CS. Predictors of severe pain during insertion of the levonorgestrel 52 mg intrauterine system among nulligravid women [Internet]. Contraception. 2020 ; 102( 4): 267-269.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2020.07.004
Artigo de periodico
A pilot study of levonorgestrel concentrations and bleeding patterns in women with epilepsy using a levonorgestrel IUD and treated with antiepileptic drugs (2019)
Vieira, Carolina Sales ; Pack, Alison; Roberts, Kevin; Davis, Anne R.
Source: Contraception. Unidade: FMRP
Subjects: DISPOSITIVOS INTRAUTERINOS, EPILEPSIA, ANTIPSICÓTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIEIRA, Carolina Sales et al. A pilot study of levonorgestrel concentrations and bleeding patterns in women with epilepsy using a levonorgestrel IUD and treated with antiepileptic drugs. Contraception, v. 99, n. 4, p. 251-255, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.contraception.2018.11.018. Acesso em: 12 maio 2024.
APA
Vieira, C. S., Pack, A., Roberts, K., & Davis, A. R. (2019). A pilot study of levonorgestrel concentrations and bleeding patterns in women with epilepsy using a levonorgestrel IUD and treated with antiepileptic drugs. Contraception, 99( 4), 251-255. doi:10.1016/j.contraception.2018.11.018
NLM
Vieira CS, Pack A, Roberts K, Davis AR. A pilot study of levonorgestrel concentrations and bleeding patterns in women with epilepsy using a levonorgestrel IUD and treated with antiepileptic drugs [Internet]. Contraception. 2019 ; 99( 4): 251-255.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2018.11.018
Vancouver
Vieira CS, Pack A, Roberts K, Davis AR. A pilot study of levonorgestrel concentrations and bleeding patterns in women with epilepsy using a levonorgestrel IUD and treated with antiepileptic drugs [Internet]. Contraception. 2019 ; 99( 4): 251-255.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2018.11.018
Artigo de periodico
Bleeding profile associated with 1-year use of the segesterone acetate/ethinyl estradiol contraceptive vaginal system: pooled analysis from Phase 3 trials (2019)
Vieira, Carolina Sales ; Fraser, Ian S.; Plagianos, Marlene G.; Burke, Anne E.; Westhoff, Carolyn L.; Jensen, Jeffrey; Brache, Vivian; Bahamondes, Luis; Merkatz, Ruth; Sitruk-Ware, Regine; Blithe, Diana L.
Source: Contraception. Unidade: FMRP
Subjects: PROGESTINAS, CONTROLE DE NATALIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIEIRA, Carolina Sales et al. Bleeding profile associated with 1-year use of the segesterone acetate/ethinyl estradiol contraceptive vaginal system: pooled analysis from Phase 3 trials. Contraception, v. 100, n. 6, p. 438-444, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.contraception.2019.07.145. Acesso em: 12 maio 2024.
APA
Vieira, C. S., Fraser, I. S., Plagianos, M. G., Burke, A. E., Westhoff, C. L., Jensen, J., et al. (2019). Bleeding profile associated with 1-year use of the segesterone acetate/ethinyl estradiol contraceptive vaginal system: pooled analysis from Phase 3 trials. Contraception, 100( 6), 438-444. doi:10.1016/j.contraception.2019.07.145
NLM
Vieira CS, Fraser IS, Plagianos MG, Burke AE, Westhoff CL, Jensen J, Brache V, Bahamondes L, Merkatz R, Sitruk-Ware R, Blithe DL. Bleeding profile associated with 1-year use of the segesterone acetate/ethinyl estradiol contraceptive vaginal system: pooled analysis from Phase 3 trials [Internet]. Contraception. 2019 ; 100( 6): 438-444.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2019.07.145
Vancouver
Vieira CS, Fraser IS, Plagianos MG, Burke AE, Westhoff CL, Jensen J, Brache V, Bahamondes L, Merkatz R, Sitruk-Ware R, Blithe DL. Bleeding profile associated with 1-year use of the segesterone acetate/ethinyl estradiol contraceptive vaginal system: pooled analysis from Phase 3 trials [Internet]. Contraception. 2019 ; 100( 6): 438-444.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2019.07.145
Artigo de periodico
Timing of postpartum etonogestrel-releasing implant insertion and bleeding patterns, weight change, 12-month continuation and satisfaction rates: a randomized controlled trial (2019)
Vieira, Carolina Sales ; Nadai, Mariane Nunes de ; Carmo, Lilian Sheila de Melo Pereira do; Braga, Giordana Campos ; Infante, Bruna Fregonesi; Stifani, Bianca M.; Ferriani, Rui Alberto ; Quintana, Silvana Maria
Source: Contraception. Unidade: FMRP
Subjects: CONTROLE DE NATALIDADE, FÁRMACOS (SISTEMA REPRODUTOR)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIEIRA, Carolina Sales et al. Timing of postpartum etonogestrel-releasing implant insertion and bleeding patterns, weight change, 12-month continuation and satisfaction rates: a randomized controlled trial. Contraception, v. 100, n. 4, p. 258-263, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.contraception.2019.05.007. Acesso em: 12 maio 2024.
APA
Vieira, C. S., Nadai, M. N. de, Carmo, L. S. de M. P. do, Braga, G. C., Infante, B. F., Stifani, B. M., et al. (2019). Timing of postpartum etonogestrel-releasing implant insertion and bleeding patterns, weight change, 12-month continuation and satisfaction rates: a randomized controlled trial. Contraception, 100( 4), 258-263. doi:10.1016/j.contraception.2019.05.007
NLM
Vieira CS, Nadai MN de, Carmo LS de MP do, Braga GC, Infante BF, Stifani BM, Ferriani RA, Quintana SM. Timing of postpartum etonogestrel-releasing implant insertion and bleeding patterns, weight change, 12-month continuation and satisfaction rates: a randomized controlled trial [Internet]. Contraception. 2019 ; 100( 4): 258-263.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2019.05.007
Vancouver
Vieira CS, Nadai MN de, Carmo LS de MP do, Braga GC, Infante BF, Stifani BM, Ferriani RA, Quintana SM. Timing of postpartum etonogestrel-releasing implant insertion and bleeding patterns, weight change, 12-month continuation and satisfaction rates: a randomized controlled trial [Internet]. Contraception. 2019 ; 100( 4): 258-263.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2019.05.007
Artigo de periodico
Can initial vaginal bleeding patterns in etonogestrel implant users predict subsequent bleeding in the first 2 years of use ? (2019)
Mansour, Diana; Fraser, Ian S; Edelman, Alison; Vieira, Carolina Sales ; Kaunitz, Andrew M.; Korver, Tjeerd; Pong, Annpey; Lin, Jianxin; Shah, Arvind K.; Fox, Michelle; Rekers, Hans; Creinin, Mitchell D.
Source: Contraception. Unidade: FMRP
Subjects: FÁRMACOS (SISTEMA UROGENITAL), PROGESTERONA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MANSOUR, Diana et al. Can initial vaginal bleeding patterns in etonogestrel implant users predict subsequent bleeding in the first 2 years of use ?. Contraception, v. 100, n. 4, p. 264-268, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.contraception.2019.05.017. Acesso em: 12 maio 2024.
APA
Mansour, D., Fraser, I. S., Edelman, A., Vieira, C. S., Kaunitz, A. M., Korver, T., et al. (2019). Can initial vaginal bleeding patterns in etonogestrel implant users predict subsequent bleeding in the first 2 years of use ? Contraception, 100( 4), 264-268. doi:10.1016/j.contraception.2019.05.017
NLM
Mansour D, Fraser IS, Edelman A, Vieira CS, Kaunitz AM, Korver T, Pong A, Lin J, Shah AK, Fox M, Rekers H, Creinin MD. Can initial vaginal bleeding patterns in etonogestrel implant users predict subsequent bleeding in the first 2 years of use ? [Internet]. Contraception. 2019 ; 100( 4): 264-268.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2019.05.017
Vancouver
Mansour D, Fraser IS, Edelman A, Vieira CS, Kaunitz AM, Korver T, Pong A, Lin J, Shah AK, Fox M, Rekers H, Creinin MD. Can initial vaginal bleeding patterns in etonogestrel implant users predict subsequent bleeding in the first 2 years of use ? [Internet]. Contraception. 2019 ; 100( 4): 264-268.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2019.05.017
Artigo de periodico
Factors associated with nonadherence to instructions for using the Nestorone®/ethinyl estradiol contraceptive vaginal ring (2018)
Stifani, Bianca M.; Plagianos, Marlena; Vieira, Carolina Sales; Merkatz, Ruth B.
Source: Contraception. Unidade: FMRP
Subjects: ANTICONCEPÇÃO, DISPOSITIVOS ANTICONCEPCIONAIS, ESTRADIOL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
STIFANI, Bianca M. et al. Factors associated with nonadherence to instructions for using the Nestorone®/ethinyl estradiol contraceptive vaginal ring. Contraception, v. 97, n. 5, p. 415-421, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.contraception.2017.12.011. Acesso em: 12 maio 2024.
APA
Stifani, B. M., Plagianos, M., Vieira, C. S., & Merkatz, R. B. (2018). Factors associated with nonadherence to instructions for using the Nestorone®/ethinyl estradiol contraceptive vaginal ring. Contraception, 97( 5), 415-421. doi:10.1016/j.contraception.2017.12.011
NLM
Stifani BM, Plagianos M, Vieira CS, Merkatz RB. Factors associated with nonadherence to instructions for using the Nestorone®/ethinyl estradiol contraceptive vaginal ring [Internet]. Contraception. 2018 ; 97( 5): 415-421.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2017.12.011
Vancouver
Stifani BM, Plagianos M, Vieira CS, Merkatz RB. Factors associated with nonadherence to instructions for using the Nestorone®/ethinyl estradiol contraceptive vaginal ring [Internet]. Contraception. 2018 ; 97( 5): 415-421.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2017.12.011
Artigo de periodico
Immediate postpartum initiation of etonogestrel-releasing implant: a randomized controlled trial on breastfeeding impact (2015)
Braga, Giordana Campos; Ferriolli, Eduardo; Quintana, Silvana Maria; Ferriani, Rui Alberto; Pfrimer, Karina; Vieira, Carolina Sales
Source: Contraception. Unidade: FMRP
Subjects: ALEITAMENTO MATERNO, HORMÔNIOS, PRÓTESES E IMPLANTES, PUERPÉRIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRAGA, Giordana Campos et al. Immediate postpartum initiation of etonogestrel-releasing implant: a randomized controlled trial on breastfeeding impact. Contraception, v. 92, p. 536-542, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.contraception.2015.07.009. Acesso em: 12 maio 2024.
APA
Braga, G. C., Ferriolli, E., Quintana, S. M., Ferriani, R. A., Pfrimer, K., & Vieira, C. S. (2015). Immediate postpartum initiation of etonogestrel-releasing implant: a randomized controlled trial on breastfeeding impact. Contraception, 92, 536-542. doi:10.1016/j.contraception.2015.07.009
NLM
Braga GC, Ferriolli E, Quintana SM, Ferriani RA, Pfrimer K, Vieira CS. Immediate postpartum initiation of etonogestrel-releasing implant: a randomized controlled trial on breastfeeding impact [Internet]. Contraception. 2015 ; 92 536-542.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2015.07.009
Vancouver
Braga GC, Ferriolli E, Quintana SM, Ferriani RA, Pfrimer K, Vieira CS. Immediate postpartum initiation of etonogestrel-releasing implant: a randomized controlled trial on breastfeeding impact [Internet]. Contraception. 2015 ; 92 536-542.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2015.07.009
Artigo de periodico
Oral anticoagulant therapy does not modify the bleeding pattern associated with the levonorgestrel-releasing intrauterine system in women with thrombophilia and/or a history of thrombosis (2014)
Braga, Giordana Campos; Brito, Milena Bastos; Ferriani, Rui Alberto; Oliveira, Luciana Correa; Garcia, Andrea Aparecida; Pintão, Maria Carolina; Vieira, Carolina Sales
Source: Contraception. Unidade: FMRP
Subjects: TROMBOSE, ANTICOAGULANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRAGA, Giordana Campos et al. Oral anticoagulant therapy does not modify the bleeding pattern associated with the levonorgestrel-releasing intrauterine system in women with thrombophilia and/or a history of thrombosis. Contraception, v. 89, n. 1, p. 48-53, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.contraception.2013.06.012. Acesso em: 12 maio 2024.
APA
Braga, G. C., Brito, M. B., Ferriani, R. A., Oliveira, L. C., Garcia, A. A., Pintão, M. C., & Vieira, C. S. (2014). Oral anticoagulant therapy does not modify the bleeding pattern associated with the levonorgestrel-releasing intrauterine system in women with thrombophilia and/or a history of thrombosis. Contraception, 89( 1), 48-53. doi:10.1016/j.contraception.2013.06.012
NLM
Braga GC, Brito MB, Ferriani RA, Oliveira LC, Garcia AA, Pintão MC, Vieira CS. Oral anticoagulant therapy does not modify the bleeding pattern associated with the levonorgestrel-releasing intrauterine system in women with thrombophilia and/or a history of thrombosis [Internet]. Contraception. 2014 ; 89( 1): 48-53.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2013.06.012
Vancouver
Braga GC, Brito MB, Ferriani RA, Oliveira LC, Garcia AA, Pintão MC, Vieira CS. Oral anticoagulant therapy does not modify the bleeding pattern associated with the levonorgestrel-releasing intrauterine system in women with thrombophilia and/or a history of thrombosis [Internet]. Contraception. 2014 ; 89( 1): 48-53.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2013.06.012
Artigo de periodico
Association of estrogen receptor alpha gene polymorphisms with autonomic modulation of heart rate in users and nonusers of oral contraceptives (2013)
Rebelo, Ana Cristina Silva; Verlengia, Rozangela; Kunz, Vandeni Clarice; Tamburus, Nayara Y; Sá, Marcos Felipe Silva de; Hirata, Rosario Dominguez Crespo ; Cerda, Alvaro; Hirata, Mario Hiroyuki ; Silva, Ester da
Source: Contraception. Unidades: FMRP, FCF
Subjects: POLIMORFISMO, ESTRÓGENOS, SISTEMA NERVOSO AUTÔNOMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REBELO, Ana Cristina Silva et al. Association of estrogen receptor alpha gene polymorphisms with autonomic modulation of heart rate in users and nonusers of oral contraceptives. Contraception, v. 88, n. 1, p. 183-188, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.contraception.2012.11.001. Acesso em: 12 maio 2024.
APA
Rebelo, A. C. S., Verlengia, R., Kunz, V. C., Tamburus, N. Y., Sá, M. F. S. de, Hirata, R. D. C., et al. (2013). Association of estrogen receptor alpha gene polymorphisms with autonomic modulation of heart rate in users and nonusers of oral contraceptives. Contraception, 88( 1), 183-188. doi:10.1016/j.contraception.2012.11.001
NLM
Rebelo ACS, Verlengia R, Kunz VC, Tamburus NY, Sá MFS de, Hirata RDC, Cerda A, Hirata MH, Silva E da. Association of estrogen receptor alpha gene polymorphisms with autonomic modulation of heart rate in users and nonusers of oral contraceptives [Internet]. Contraception. 2013 ; 88( 1): 183-188.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2012.11.001
Vancouver
Rebelo ACS, Verlengia R, Kunz VC, Tamburus NY, Sá MFS de, Hirata RDC, Cerda A, Hirata MH, Silva E da. Association of estrogen receptor alpha gene polymorphisms with autonomic modulation of heart rate in users and nonusers of oral contraceptives [Internet]. Contraception. 2013 ; 88( 1): 183-188.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2012.11.001
Artigo de periodico
Effects of combined oral contraceptives containing levonorgestrel or chlormadinone on the endothelium (2013)
Franceschini, Silvio Antonio; Vieira, Carolina Sales; Martins, Wellington de Paula; França, Janaína Boldrini; Ferriani, Rui Alberto
Source: Contraception. Unidade: FMRP
Subjects: DISPOSITIVOS ANTICONCEPCIONAIS FEMININOS, ENDOTÉLIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRANCESCHINI, Silvio Antonio et al. Effects of combined oral contraceptives containing levonorgestrel or chlormadinone on the endothelium. Contraception, v. 87, n. 6, p. 766-772, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.contraception.2012.09.023. Acesso em: 12 maio 2024.
APA
Franceschini, S. A., Vieira, C. S., Martins, W. de P., França, J. B., & Ferriani, R. A. (2013). Effects of combined oral contraceptives containing levonorgestrel or chlormadinone on the endothelium. Contraception, 87( 6), 766-772. doi:10.1016/j.contraception.2012.09.023
NLM
Franceschini SA, Vieira CS, Martins W de P, França JB, Ferriani RA. Effects of combined oral contraceptives containing levonorgestrel or chlormadinone on the endothelium [Internet]. Contraception. 2013 ; 87( 6): 766-772.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2012.09.023
Vancouver
Franceschini SA, Vieira CS, Martins W de P, França JB, Ferriani RA. Effects of combined oral contraceptives containing levonorgestrel or chlormadinone on the endothelium [Internet]. Contraception. 2013 ; 87( 6): 766-772.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2012.09.023
Artigo de periodico
The relationship between perinatal psychiatric disorders and contraception use among postpartum women (2013)
Faisal-Cury, Alexandre; Menezes, Paulo Rossi; Huang, Hsiang
Source: Contraception. Unidade: FM
Subjects: TRANSTORNOS MENTAIS, DEPRESSÃO PÓS-PARTO, SAÚDE DA MULHER, ATENÇÃO PRIMÀRIA À SAÙDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FAISAL-CURY, Alexandre e MENEZES, Paulo Rossi e HUANG, Hsiang. The relationship between perinatal psychiatric disorders and contraception use among postpartum women. Contraception, v. 88, n. 4, p. 498-502, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.contraception.2013.02.003. Acesso em: 12 maio 2024.
APA
Faisal-Cury, A., Menezes, P. R., & Huang, H. (2013). The relationship between perinatal psychiatric disorders and contraception use among postpartum women. Contraception, 88( 4), 498-502. doi:10.1016/j.contraception.2013.02.003
NLM
Faisal-Cury A, Menezes PR, Huang H. The relationship between perinatal psychiatric disorders and contraception use among postpartum women [Internet]. Contraception. 2013 ; 88( 4): 498-502.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2013.02.003
Vancouver
Faisal-Cury A, Menezes PR, Huang H. The relationship between perinatal psychiatric disorders and contraception use among postpartum women [Internet]. Contraception. 2013 ; 88( 4): 498-502.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2013.02.003
Artigo de periodico
A combined oral contraceptive containing drospirenone changes neither endothelial function nor hemodynamic parameters in healthy young women: a prospective clinical trial (2012)
Giribela, Cassiana R. G; Melo, Nilson R; Silva, Rita de Cassia Gengo e; Hong, Valeria M; Guerra, Grazia M; Baracat, Edmund Chada; Consolim-Colombo, Fernanda M
Source: Contraception. Unidades: EE, FM
Subjects: PRESSÃO SANGUÍNEA, ENDOTÉLIO, HEMODINÂMICA, ANTICONCEPÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIRIBELA, Cassiana R. G et al. A combined oral contraceptive containing drospirenone changes neither endothelial function nor hemodynamic parameters in healthy young women: a prospective clinical trial. Contraception, v. 86, n. 1, p. 35-41, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.contraception.2011.08.017. Acesso em: 12 maio 2024.
APA
Giribela, C. R. G., Melo, N. R., Silva, R. de C. G. e, Hong, V. M., Guerra, G. M., Baracat, E. C., & Consolim-Colombo, F. M. (2012). A combined oral contraceptive containing drospirenone changes neither endothelial function nor hemodynamic parameters in healthy young women: a prospective clinical trial. Contraception, 86( 1), 35-41. doi:10.1016/j.contraception.2011.08.017
NLM
Giribela CRG, Melo NR, Silva R de CG e, Hong VM, Guerra GM, Baracat EC, Consolim-Colombo FM. A combined oral contraceptive containing drospirenone changes neither endothelial function nor hemodynamic parameters in healthy young women: a prospective clinical trial [Internet]. Contraception. 2012 ; 86( 1): 35-41.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2011.08.017
Vancouver
Giribela CRG, Melo NR, Silva R de CG e, Hong VM, Guerra GM, Baracat EC, Consolim-Colombo FM. A combined oral contraceptive containing drospirenone changes neither endothelial function nor hemodynamic parameters in healthy young women: a prospective clinical trial [Internet]. Contraception. 2012 ; 86( 1): 35-41.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2011.08.017
Artigo de periodico
Drospirenone and levonorgestrel in combination with either 30 or 20 mcg ethinylestradiol reduce soluble adhesion molecules in Brazilian women: cross-sectional study (2012)
Stocco, Bianca; Fumagalli, Helen Figueiredo; Franceschini, Silvio Antonio; Martinez, Edson Zangiacomi; Marzocchi-Machado, Cleni Mara; Toloi, Maria Regina Torqueti
Source: Contraception. Unidades: FCFRP, FMRP
Subjects: ARTERIOSCLEROSE, DISPOSITIVOS ANTICONCEPCIONAIS (COMBINAÇÃO;EFEITOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
STOCCO, Bianca et al. Drospirenone and levonorgestrel in combination with either 30 or 20 mcg ethinylestradiol reduce soluble adhesion molecules in Brazilian women: cross-sectional study. Contraception, v. 86, n. 5, p. 506-510, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.contraception.2012.03.013. Acesso em: 12 maio 2024.
APA
Stocco, B., Fumagalli, H. F., Franceschini, S. A., Martinez, E. Z., Marzocchi-Machado, C. M., & Toloi, M. R. T. (2012). Drospirenone and levonorgestrel in combination with either 30 or 20 mcg ethinylestradiol reduce soluble adhesion molecules in Brazilian women: cross-sectional study. Contraception, 86( 5), 506-510. doi:10.1016/j.contraception.2012.03.013
NLM
Stocco B, Fumagalli HF, Franceschini SA, Martinez EZ, Marzocchi-Machado CM, Toloi MRT. Drospirenone and levonorgestrel in combination with either 30 or 20 mcg ethinylestradiol reduce soluble adhesion molecules in Brazilian women: cross-sectional study [Internet]. Contraception. 2012 ; 86( 5): 506-510.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2012.03.013
Vancouver
Stocco B, Fumagalli HF, Franceschini SA, Martinez EZ, Marzocchi-Machado CM, Toloi MRT. Drospirenone and levonorgestrel in combination with either 30 or 20 mcg ethinylestradiol reduce soluble adhesion molecules in Brazilian women: cross-sectional study [Internet]. Contraception. 2012 ; 86( 5): 506-510.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2012.03.013
Artigo de periodico
The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome. (2012)
Vieira, Carolina Sales; Martins, Wellington de P.; Fernandes, Janaína Boldrini França; Soares, Gustavo Mafaldo; Reis, Rosana Maria dos; Sá, Marcos Felipe Silva de; Ferriani, Rui Alberto
Source: Contraception. Unidade: FMRP
Subjects: SÍNDROME DO OVÁRIO POLICÍSTICO, DISPOSITIVOS ANTICONCEPCIONAIS FEMININOS, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIEIRA, Carolina Sales et al. The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome. Contraception, v. 86, n. 3, p. 268-275, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.contraception.2011.12.11. Acesso em: 12 maio 2024.
APA
Vieira, C. S., Martins, W. de P., Fernandes, J. B. F., Soares, G. M., Reis, R. M. dos, Sá, M. F. S. de, & Ferriani, R. A. (2012). The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome. Contraception, 86( 3), 268-275. doi:10.1016/j.contraception.2011.12.11
NLM
Vieira CS, Martins W de P, Fernandes JBF, Soares GM, Reis RM dos, Sá MFS de, Ferriani RA. The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome. [Internet]. Contraception. 2012 ; 86( 3): 268-275.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2011.12.11
Vancouver
Vieira CS, Martins W de P, Fernandes JBF, Soares GM, Reis RM dos, Sá MFS de, Ferriani RA. The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome. [Internet]. Contraception. 2012 ; 86( 3): 268-275.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2011.12.11
Artigo de periodico
Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue (2010)
Ferreira, Rodrigo Alves; Vieira, Carolina Sales; Rosa e Silva, Júlio César; Rosa e Silva, Ana Carolina Japur de Sá; Nogueira, Antonio Alberto; Ferriani, Rui Alberto
Source: Contraception. Unidade: FMRP
Subjects: ENDOMETRIOSE, DOENÇAS CARDIOVASCULARES, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Rodrigo Alves et al. Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue. Contraception, v. 81, n. 2, p. 117-122, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.contraception.2009.08.003. Acesso em: 12 maio 2024.
APA
Ferreira, R. A., Vieira, C. S., Rosa e Silva, J. C., Rosa e Silva, A. C. J. de S., Nogueira, A. A., & Ferriani, R. A. (2010). Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue. Contraception, 81( 2), 117-122. doi:10.1016/j.contraception.2009.08.003
NLM
Ferreira RA, Vieira CS, Rosa e Silva JC, Rosa e Silva ACJ de S, Nogueira AA, Ferriani RA. Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue [Internet]. Contraception. 2010 ; 81( 2): 117-122.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2009.08.003
Vancouver
Ferreira RA, Vieira CS, Rosa e Silva JC, Rosa e Silva ACJ de S, Nogueira AA, Ferriani RA. Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue [Internet]. Contraception. 2010 ; 81( 2): 117-122.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2009.08.003
Artigo de periodico
Effect of low-dose combined oral contraceptive on aerobic capacity and anaerobic threshold level in active and sedentary young women (2010)
Rebelo, Ana Cristina S.; Zuttin, Roberta S.; Verlengia, Rozangela; Cesar, Marcelo de C.; Sá, Marcos Felipe Silva de; Silva, Ester da
Source: Contraception. Unidade: FMRP
Assunto: DISPOSITIVOS ANTICONCEPCIONAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REBELO, Ana Cristina S. et al. Effect of low-dose combined oral contraceptive on aerobic capacity and anaerobic threshold level in active and sedentary young women. Contraception, v. 81, n. 4, p. 309-315, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.contraception.2009.11.005. Acesso em: 12 maio 2024.
APA
Rebelo, A. C. S., Zuttin, R. S., Verlengia, R., Cesar, M. de C., Sá, M. F. S. de, & Silva, E. da. (2010). Effect of low-dose combined oral contraceptive on aerobic capacity and anaerobic threshold level in active and sedentary young women. Contraception, 81( 4), 309-315. doi:10.1016/j.contraception.2009.11.005
NLM
Rebelo ACS, Zuttin RS, Verlengia R, Cesar M de C, Sá MFS de, Silva E da. Effect of low-dose combined oral contraceptive on aerobic capacity and anaerobic threshold level in active and sedentary young women [Internet]. Contraception. 2010 ; 81( 4): 309-315.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2009.11.005
Vancouver
Rebelo ACS, Zuttin RS, Verlengia R, Cesar M de C, Sá MFS de, Silva E da. Effect of low-dose combined oral contraceptive on aerobic capacity and anaerobic threshold level in active and sedentary young women [Internet]. Contraception. 2010 ; 81( 4): 309-315.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2009.11.005
Artigo de periodico
Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study (2009)
Brito, Milena Bastos; Ferriani, Rui Alberto; Quintana, Silvana Maria; Yazlle, Marta Edna Holanda Diogenes; Sá, Marcos Felipe Silva de; Vieira, Carolina Sales
Source: Contraception. Unidade: FMRP
Subjects: ALEITAMENTO MATERNO, DISPOSITIVOS ANTICONCEPCIONAIS FEMININOS (EFEITOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRITO, Milena Bastos et al. Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study. Contraception, v. 80, n. 6, p. 519-526, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.contraception.2009.05.124. Acesso em: 12 maio 2024.
APA
Brito, M. B., Ferriani, R. A., Quintana, S. M., Yazlle, M. E. H. D., Sá, M. F. S. de, & Vieira, C. S. (2009). Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study. Contraception, 80( 6), 519-526. doi:10.1016/j.contraception.2009.05.124
NLM
Brito MB, Ferriani RA, Quintana SM, Yazlle MEHD, Sá MFS de, Vieira CS. Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study [Internet]. Contraception. 2009 ; 80( 6): 519-526.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2009.05.124
Vancouver
Brito MB, Ferriani RA, Quintana SM, Yazlle MEHD, Sá MFS de, Vieira CS. Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study [Internet]. Contraception. 2009 ; 80( 6): 519-526.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2009.05.124
Artigo de periodico
Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women (2009)
Lizarelli, Patrícia Margareth; Martins, Wellington de Paula; Soares, Gustavo Mafaldo; Macedo, Carolina Sales Vieira; Franceschini, Silvio Antonio; Ferriani, Rui Alberto; Patta, Maristela Carbol
Source: Contraception. Unidade: FMRP
Subjects: DISPOSITIVOS ANTICONCEPCIONAIS, ENDOTÉLIO, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIZARELLI, Patrícia Margareth et al. Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women. Contraception, v. 79, n. 1, p. 35-40, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.contraception.2008.07.024. Acesso em: 12 maio 2024.
APA
Lizarelli, P. M., Martins, W. de P., Soares, G. M., Macedo, C. S. V., Franceschini, S. A., Ferriani, R. A., & Patta, M. C. (2009). Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women. Contraception, 79( 1), 35-40. doi:10.1016/j.contraception.2008.07.024
NLM
Lizarelli PM, Martins W de P, Soares GM, Macedo CSV, Franceschini SA, Ferriani RA, Patta MC. Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women [Internet]. Contraception. 2009 ; 79( 1): 35-40.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2008.07.024
Vancouver
Lizarelli PM, Martins W de P, Soares GM, Macedo CSV, Franceschini SA, Ferriani RA, Patta MC. Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women [Internet]. Contraception. 2009 ; 79( 1): 35-40.[citado 2024 maio 12 ] Available from: https://doi.org/10.1016/j.contraception.2008.07.024

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration